Scarica l'app Stockscreener
3.365
0.00%
0.005
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.37
Aprire:
$3.37
Volume 24 ore:
31,612
Relative Volume:
0.03
Capitalizzazione di mercato:
$581.60M
Reddito:
-
Utile/perdita netta:
$-54.70M
Rapporto P/E:
-10.20
EPS:
-0.33
Flusso di cassa netto:
$-51.36M
1 W Prestazione:
-2.60%
1M Prestazione:
-5.34%
6M Prestazione:
+15.41%
1 anno Prestazione:
-10.61%
Intervallo 1D:
$3.35
$3.4489
Intervallo di 1 settimana:
$3.34
$3.53
Portata 52W:
$1.89
$4.295
Savara Inc Stock (SVRA) Company Profile
Nome
Savara Inc
Settore
Industria
Telefono
51285113796
Indirizzo
6836 BEE CAVE ROAD, AUSTIN, TX
Confronta SVRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SVRA
Savara Inc
|
3.365 | 582.46M | 0 | -54.70M | -51.36M | -0.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.74 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.18 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.12 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.26 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
329.04 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Savara Inc Stock (SVRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-15 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-05-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-12-20 | Iniziato | Wells Fargo | Overweight |
| 2024-11-13 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-02-15 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-11-07 | Iniziato | Guggenheim | Buy |
| 2023-05-16 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-03-31 | Downgrade | Jefferies | Buy → Hold |
| 2021-03-16 | Iniziato | Piper Sandler | Overweight |
| 2021-03-15 | Iniziato | Oppenheimer | Outperform |
| 2019-06-13 | Reiterato | H.C. Wainwright | Buy |
| 2019-06-13 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-06-13 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2018-08-13 | Ripresa | ROTH Capital | Neutral |
| 2018-01-03 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-09-27 | Ripresa | ROTH Capital | Buy |
| 2017-09-22 | Iniziato | Jefferies | Buy |
| 2017-09-11 | Iniziato | JMP Securities | Mkt Outperform |
Mostra tutto
Savara Inc Borsa (SVRA) Ultime notizie
November 7, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against SVRA - PR Newswire
Securities Fraud Class Action Filed Against Savara Inc. (SVRA)Levi & Korsinsky Reminds Investors of November 7, 2025 - ACCESS Newswire
SVRA INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - GlobeNewswire
SVRA INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - GlobeNewswire Inc.
SAVARA ALERT: Bragar Eagel & Squire, P.C. Urges Investors - GlobeNewswire
SVRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
How to forecast Savara Inc. trends using time series2025 Stock Rankings & Free Verified High Yield Trade Plans - newser.com
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - PR Newswire
Shareholders that lost money on Savara Inc.(SVRA) should contact The Gross Law Firm about pending Class ActionSVRA - Morningstar
Savara: Back On Track With Upcoming APAP BLA Filing (NASDAQ:SVRA) - Seeking Alpha
Weiss Ratings Reaffirms Sell (D-) Rating for Savara (NASDAQ:SVRA) - Defense World
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Savara Inc. - GlobeNewswire
Savara Inc. INVESTOR ALERT: Kirby McInerney LLP Reminds Savara Inc. Investors of Looming Lead ... - Bluefield Daily Telegraph
Savara Inc. INVESTOR ALERT: Kirby McInerney LLP Reminds Savara Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit | Franklin Credit Management Corporation - FinancialContent
Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain OfficersSVRA - PR Newswire
SVRA DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - GlobeNewswire
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit - Your Wyoming Link
Savara Inc. (SVRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Lost Money on Savara Inc. (SVRA)? Urged to Join Class Action Before November 7, 2025Contact Levi & Korsinsky - ACCESS Newswire
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Lost Money on Savara Inc. (SVRA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire
Securities Lawsuit Alert: Savara Inc. (SVRA)Contact Levi & Korsinsky Before November 7, 2025 - ACCESS Newswire
Savara Inc. INVESTOR ALERT: Kirby McInerney LLP Reminds - GlobeNewswire
Deadline Alert: Savara Inc. (SVRA) Shareholders Who Lost - GlobeNewswire
SAVARA CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. - GlobeNewswire
SVRA LAWSUIT ALERT: Levi & Korsinsky Notifies Savara Inc. InvestorsLead Plaintiff Deadline November 7, 2025 - ACCESS Newswire
About Us - FinancialContent
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 7, 2025 in Savara Inc. LawsuitSVRA - Morningstar
Did You Lose Money on Savara Inc. (SVRA)? Levi & Korsinsky Urges Investors to Act Before November 7, 2025 - ACCESS Newswire
Savara Inc. $SVRA Position Increased by Farther Finance Advisors LLC - Defense World
Levi & Korsinsky Urges Savara Inc. (SVRA) Shareholders to Act Before Lead Plaintiff Deadline November 7, 2025 - ACCESS Newswire
Bragar Eagel & Squire, P.C. Urges Investors of Tronox, - GlobeNewswire
Faruqi & Faruqi Reminds Savara Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2025SVRA - Newsfile
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - MarketScreener
Savara Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationSVRA - FinancialContent
Quantitative breakdown of Savara Inc. recent moveLong Setup & Fast Entry and Exit Trade Plans - newser.com
What indicators show strength in Savara Inc.Insider Buying & Comprehensive Market Scan Insights - newser.com
Savara Announces Encore Presentations of Results From the Phase 3 IMPALA-2 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at CHEST 2025 - BioSpace
Why Savara Inc. stock could benefit from AI revolution2025 Key Lessons & Fast Exit and Entry Trade Guides - newser.com
Savara Inc. stock trend outlook and recovery pathProduct Launch & Real-Time Stock Movement Alerts - newser.com
SVRA NOTICE: Savara Inc. Investors Urged to Contact Kirby McInerney LLP About Securities Fraud Lawsuit - GlobeNewswire
MarketsMedicine Hat News - FinancialContent
Savara to present aPAP diagnosis test data at CHEST 2025 - Investing.com
Savara (SVRA) to Showcase Research at CHEST 2025 Conference - GuruFocus
Savara to present aPAP diagnosis test data at CHEST 2025 By Investing.com - Investing.com Australia
Savara present results from Phase 3 IMPALA-2 Molgramostim study - TipRanks
3 CHEST 2025 Abstracts: Savara Presents Phase 3 IMPALA-2 Molgramostim Data, TrilliumBiO Dried Serum Test - Stock Titan
SVRA Investors Have Opportunity to Lead Savara Inc. Securities F - GuruFocus
Upcoming Virtual Meeting Features SVRA on October 8-9 - GuruFocus
Levi & Korsinsky Notifies Savara Inc. (SVRA) InvestorsLead Plaintiff Deadline on November 7, 2025 - ACCESS Newswire
Investor Alert: Deadline Approaching to Join Savara Inc. (SVRA) Class ActionContact Levi & Korsinsky - ACCESS Newswire
Savara Inc Azioni (SVRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Savara Inc Azioni (SVRA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| McCracken Joseph S | Director |
May 29 '25 |
Buy |
2.08 |
10,000 |
20,825 |
260,837 |
| RAMSAY DAVID A | Director |
Mar 31 '25 |
Buy |
2.77 |
150,000 |
416,250 |
2,513,642 |
| Lowrance David L | Chief Financial Officer |
Dec 16 '24 |
Sale |
3.33 |
25,000 |
83,278 |
381,005 |
| Pauls Matthew | CHIEF EXECUTIVE OFFICER |
Dec 16 '24 |
Sale |
3.31 |
54,702 |
180,828 |
1,536,379 |
| Hawkins Richard J | Director |
Dec 16 '24 |
Sale |
3.32 |
8,000 |
26,569 |
67,241 |
0.21%
2.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):